Latest Viatris News & Updates

See the latest news and media coverage for Viatris. We track all announcements, press releases, and industry mentions in real time, all in one place.

Viatris

Global healthcare company

viatris.com

Headquarters: Pittsburgh, United States
Company type: Public company
Number of employees: 15,000+
Industry: Pharmaceuticals

Last updated Today

Latest news about Viatris

In short: Viatris reported strong earnings growth, secured FDA approval for a new contraceptive patch, and outlined strategic targets through 2030.

Company announcements

Today Viatris

Viatris announces narcolepsy drug approval in Japan

The first-in-class treatment for excessive daytime sleepiness advances the company's portfolio in the region.

July 29 Viatris

Viatris receives FDA approval for Gwyn Lo contraceptive patch

The patch offers low-dose estrogen once-weekly contraception with demonstrated efficacy and safety in clinical trials.

June 29 Viatris

Viatris announces positive Phase 3 results for VR-205

The study met primary and key secondary endpoints with a 33.75% UPCR reduction. Submission targeted by end of 2026.

May 18 Viatris

Viatris announces FDA acceptance of NDA for fast-acting meloxicam

The FDA set a PDUFA goal date of Dec. 27, 2026 for the non-opioid acute pain treatment.

Media coverage

Today Yahoo Finance

Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Japan's Ministry of Health, Labour and Welfare has granted approval for WAKIX® (pitolisant) for...

September 9 GuruFocus

VTRS Initiated Coverage by Leerink Partners -- Rating Set to Out

Viatris (VTRS) Receives Outperform Rating from Leerink Partners On October 10, 2023, Leerink...

September 9 Seeking Alpha

Viatris: Strong Cash Generation And Pipeline Progress Keep The Re-Rating Story Alive

Viatris' Q2 showed better earnings quality, with adjusted net income and EPS up 11% while free cash flow doubled year-over-year. Click here to read more.

August 19 Yahoo Finance

Viatris' China Policy Concerns Overstated, UBS Says

China business remains resilient despite concerns over the country's new volume-control policy, UBS Securities said in a Wednesday note. Concerns seem "overstated" given the China...

Never miss news about Viatris

Track Viatris and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Viatris competitors & trending companies

Browse news for competitors to Viatris and other trending companies.